INTERNATIONAL PATENT: DEVELOPMENT CENTER FOR BIOTECHNOLOGY, DCB-USA LLC FILES APPLICATION FOR "RECOMBINANT ANTIBODIES, CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF IN TREATING CANCERS"

GENEVA, Dec. 24 -- DEVELOPMENT CENTER FOR BIOTECHNOLOGY (No. 101, Ln. 169, Kangning St., Xizhi Dist.New Taipei City, 221), DCB-USA LLC (1007 N. Orange Street, 9th FloorWilmington, New Castle County, Delaware 19801) filed a patent application (PCT/US2025/033657) for "RECOMBINANT ANTIBODIES, CHIMERIC ANTIGEN RECEPTORS, AND USES THEREOF IN TREATING CANCERS" on Jun 13, 2025. With publication no. WO/2025/260052, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AI, Li-Shuang (No. 107, Ln. 130, Sec. 1, Academia Rd., Nangang Dist....